semaglutide and type 2 diabetes (Ozempic/Wegovy) shows 3-year efficacy for blood sugar control weight loss Semaglutide for Type-2 Diabetes vs.
Description
Even imperfect outcomes from treatment attempts beat untreated obesity
GLP-1 medications can quiet constant hunger and cravings, but they may also bring up past patterns of restriction
Being totally sedentary, which is very bad for blood sugar control
If structured weight management is the primary focus, Wegovys higher dosing framework often makes it the more suitable option
The sensitivity does not improve after several weeks on the same dose
C., & Atkinson Jr, A
